Akebia Therapeutics, Inc.

Connor, Clark & Lunn Investment Management Ltd. AKBA

Report date

12/31/2025

Quarter

2025 Q4

Filed

2/10/2026

Shares

753,906

Value ($000)

1,214

Weight

0.0%

2021 Q1 - 2025 Q4 (20 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2025 Q4	2/10/2026	1,214	0.0%	753,906	12/31/2025
2025 Q3	11/13/2025	2,786	0.0%	1,020,668	9/30/2025
2025 Q2	8/7/2025	4,298	0.0%	1,180,759	6/30/2025
2025 Q1	5/12/2025	1,862	0.0%	969,834	3/31/2025
2024 Q4	2/10/2025	1,951	0.0%	1,026,896	12/31/2024
2024 Q3	11/8/2024	1,382	0.0%	1,046,691	9/30/2024
2024 Q2	8/9/2024	1,067	0.0%	1,046,059	6/30/2024
2024 Q1	5/9/2024	1,911	0.0%	1,044,471	3/31/2024
2023 Q4	2/9/2024	769	0.0%	620,319	12/31/2023
2023 Q3	11/13/2023	712	0.0%	624,142	9/30/2023
2023 Q2	8/10/2023	563	0.0%	614,878	6/30/2023
2023 Q1	5/10/2023	170	0.0%	302,977	3/31/2023
2022 Q4	2/10/2023	69	0.0%	120,053	12/31/2022
2022 Q3	11/10/2022	161	0.0%	510,102	9/30/2022
2022 Q2	8/5/2022	80	0.0%	226,770	6/30/2022
2022 Q1	5/12/2022	339	0.0%	471,681	3/31/2022
2021 Q4	2/10/2022	909	0.0%	402,416	12/31/2021
2021 Q3	11/12/2021	1,240	0.0%	430,671	9/30/2021
2021 Q2	8/12/2021	801	0.0%	211,290	6/30/2021
2021 Q1	5/13/2021	307	0.0%	90,657	3/31/2021